Suitability of methylmalonic acid and total homocysteine analysis in dried bloodspots

• Published in: Analytica chimica acta 2015-01, Vol.853, p.435-441
• Main Authors: de Sain-van der Velden, Monique G.M., van der Ham, Maria, Jans, Judith J., Visser, Gepke, van Hasselt, Peter M., Prinsen, Hubertus C.M.T., Verhoeven-Duif, Nanda M.
• Format: Article
• Language: English
• Subjects: Blood; Blood Specimen Collection; Chromatography, High Pressure Liquid; Cobalamin; Correlation; DBS; Dried blood spot; Dried Blood Spot Testing - methods; Feasibility Studies; Homocysteine; Homocysteine - biosynthesis; Homocysteine - blood; Homocysteine - secretion; Humans; Limit of Detection; Metabolism; Methylmalonic acid; Methylmalonic Acid - blood; Methylmalonic Acid - metabolism; Patients; Plasma - chemistry; Plasma - metabolism; Polymethyl methacrylates; Reproducibility of Results; Sampling; Solvents - chemistry; Spots; Tandem Mass Spectrometry; Ultra performance liquid chromatography–tandem mass spectrometry
• ISSN: 0003-2670; 1873-4324
• DOI: 10.1016/j.aca.2014.10.043

[Display omitted] •DBS assay offer sufficient sensitivity to measure MMA and tHCYS concentrations.•DBS matrix is superior for tHCYS stability.•Paired plasma and DBS samples were compared.•DBS samples for measurement of tHCYS is a good alternative approach for plasma.•For MMA, no correlation between DBS and plasma exist in the lower ranges. Methylmalonic acid (MMA) and total homocysteine (tHCYS) concentrations are used to detect acquired and inborn errors of cobalamin (vitamin B12, Cbl) metabolism and to evaluate the effect of therapeutic interventions. Dried blood spot sampling offers a patient-friendly and easy alternative to plasma sampling. However, dried blood spot concentrations are not necessarily equal to plasma concentrations. Therefore, the objective of this work was to establish the relationship between MMA and tHYS dried blood spot and plasma concentrations to facilitate clinical implementation of dried blood spot sampling. MMA and tHCYS in both plasma and DBS were validated on ultra performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS). While position of the punch (in DBS) did affect tHCYS concentration, no influence of hematocrit (Ht) and blood volume on both MMA and tHCYS concentrations was observed. The plasma assay performed better than the DBS assay by most criteria. However, the DBS matrix was superior for tHCYS stability. Paired plasma and DBS samples were obtained from patients suspected for Cbl deficiency and from patients with a known inborn error of metabolism affecting MMA or tHCYS concentration. Based on the strong correlation of tHCYS in both matrices (y=0.46±1.12 (r2=0.91)), determination of tHCYS in plasma can be replaced by tHCYS in DBS. However, for MMA, a correlation in the higher (pathological) range of MMA exist, but no correlation was observed in the lower ranges. Therefore the added value of MMA concentrations in DBS is currently unknown and should be further investigated.